<?xml version="1.0" encoding="UTF-8"?>
<p>The absorption of any potential therapeutic is a critical consideration, especially for oral dosing. Many pharmacokinetic studies of other adaptogens, including clinical trials, have been performed.
 <xref rid="med21743-bib-0339" ref-type="ref">
  <sup>339</sup>
 </xref>, 
 <xref rid="med21743-bib-0584" ref-type="ref">
  <sup>584</sup>
 </xref>, 
 <xref rid="med21743-bib-0585" ref-type="ref">
  <sup>585</sup>
 </xref>, 
 <xref rid="med21743-bib-0586" ref-type="ref">
  <sup>586</sup>
 </xref>, 
 <xref rid="med21743-bib-0587" ref-type="ref">
  <sup>587</sup>
 </xref>, 
 <xref rid="med21743-bib-0588" ref-type="ref">
  <sup>588</sup>
 </xref>, 
 <xref rid="med21743-bib-0589" ref-type="ref">
  <sup>589</sup>
 </xref>, 
 <xref rid="med21743-bib-0590" ref-type="ref">
  <sup>590</sup>
 </xref>, 
 <xref rid="med21743-bib-0591" ref-type="ref">
  <sup>591</sup>
 </xref>, 
 <xref rid="med21743-bib-0592" ref-type="ref">
  <sup>592</sup>
 </xref>, 
 <xref rid="med21743-bib-0593" ref-type="ref">
  <sup>593</sup>
 </xref>, 
 <xref rid="med21743-bib-0594" ref-type="ref">
  <sup>594</sup>
 </xref>, 
 <xref rid="med21743-bib-0595" ref-type="ref">
  <sup>595</sup>
 </xref>, 
 <xref rid="med21743-bib-0596" ref-type="ref">
  <sup>596</sup>
 </xref>, 
 <xref rid="med21743-bib-0597" ref-type="ref">
  <sup>597</sup>
 </xref>, 
 <xref rid="med21743-bib-0598" ref-type="ref">
  <sup>598</sup>
 </xref>, 
 <xref rid="med21743-bib-0599" ref-type="ref">
  <sup>599</sup>
 </xref>, 
 <xref rid="med21743-bib-0600" ref-type="ref">
  <sup>600</sup>
 </xref>, 
 <xref rid="med21743-bib-0601" ref-type="ref">
  <sup>601</sup>
 </xref>, 
 <xref rid="med21743-bib-0602" ref-type="ref">
  <sup>602</sup>
 </xref>, 
 <xref rid="med21743-bib-0603" ref-type="ref">
  <sup>603</sup>
 </xref>, 
 <xref rid="med21743-bib-0604" ref-type="ref">
  <sup>604</sup>
 </xref>, 
 <xref rid="med21743-bib-0605" ref-type="ref">
  <sup>605</sup>
 </xref>, 
 <xref rid="med21743-bib-0606" ref-type="ref">
  <sup>606</sup>
 </xref>, 
 <xref rid="med21743-bib-0607" ref-type="ref">
  <sup>607</sup>
 </xref>, 
 <xref rid="med21743-bib-0608" ref-type="ref">
  <sup>608</sup>
 </xref>, 
 <xref rid="med21743-bib-0609" ref-type="ref">
  <sup>609</sup>
 </xref>, 
 <xref rid="med21743-bib-0610" ref-type="ref">
  <sup>610</sup>
 </xref>, 
 <xref rid="med21743-bib-0611" ref-type="ref">
  <sup>611</sup>
 </xref> Some of these studies provided evidence of the level and steady‐state concentration of active compounds in the blood of human subjects who received oral administration of the herbal drugs in therapeutic doses. These concentrations were in line with those used in in vitro studies.
 <xref rid="med21743-bib-0591" ref-type="ref">
  <sup>591</sup>
 </xref>, 
 <xref rid="med21743-bib-0598" ref-type="ref">
  <sup>598</sup>
 </xref> As an example, the concentration of andrographolide (the active compound of 
 <italic>Andrographis</italic> and its combination with 
 <italic>Eleutherococcus</italic>) in blood plasma of human subjects was approximately 3.5 µM at 2 h after drug uptake,
 <xref rid="med21743-bib-0591" ref-type="ref">
  <sup>591</sup>
 </xref> which is adequate for exhibiting an anti‐PAF effect in vitro (EC50, 5 µM).
 <xref rid="med21743-bib-0440" ref-type="ref">
  <sup>440</sup>
 </xref> A comparison of the results obtained in humans and rats showed that the pharmacokinetics of andrographolide are similar in both species. It was found that andrographolide is rapidly and almost totally absorbed (T1/2abs of about 25 min) into the blood (bioavailability = 91%, 
 <italic>F</italic> = 0.91) after oral administration of Andrographis extract at a therapeutic dose (20 mg/kg). Thus, in the absorption phase, the concentration of andrographolide in the blood is not significantly changed during the first 1.5 h and increases to a maximal level 2 h after oral administration. It binds intensively with blood proteins and is redistributed between blood and tissues within 1 to 2 h. The elimination half‐time is in the range of 2–7 h.
 <xref rid="med21743-bib-0591" ref-type="ref">
  <sup>591</sup>
 </xref> The tissue distribution study of andrographolide revealed the highest tissue concentration in kidney, followed by the liver, spleen, and brain, whereas an almost identical concentration was observed in the heart and lungs.
 <xref rid="med21743-bib-0592" ref-type="ref">
  <sup>592</sup>
 </xref>
</p>
